The table below is a summary of recent safety communications for
healthcare professionals and consumers. Click on a specific topic to
go to the communication.
| Date |
Communication |
Topic |
| 22/08/2025 |
Dear Healthcare Professional Letter |
Topiramate-Actavis: New restrictions to prevent exposure during
pregnancy (PDF, 7 pages, 848 KB) |
| 14/08/2025 |
Dear Healthcare Professional Letter |
Vancomycin (as hydrochloride) – approval for European batch
to mitigate short-term gap in supply (PDF, 1 page,
114 KB) |
| 12/08/2025 |
Dear Healthcare Professional Letter |
Lenalidomide Viatris (lenalidomide) capsules – alternative registered
foils (PDF, 2 pages, 306 KB) |
| 04/08/2025 |
Dear Healthcare Professional Letter |
Ocrevus (ocrelizumab): liver injury (without findings of viral
hepatitis) (PDF, 3 pages, 219 KB) |
| 31/07/2025 |
Monitoring |
Update - Anti-CD20 monoclonal antibodies (rituximab, ocrelizumab,
obinutuzumab, ofatumumab) and the possible risk of pyoderma
gangrenosum |
| 22/07/2025 |
Alert |
Warning: advertisements claiming Medsafe approval or bearing
the Medsafe logo are scams |
| 21/07/2025 |
Dear Healthcare Professional Letter |
CellCept
(myophenolate mofetil): New important identified risk: anaphylactic
reaction (PDF, 3 pages, 135 KB) |
| 14/07/2025 |
Dear Healthcare Professional Letter |
Lenalidomide Viatris capsules (lenalidomide): labelling exemption
for alternative registered foils (PDF, 2 pages, 543 KB)
|
| 30/06/2025 |
Consumer information leaflet |
Reporting side effects of medicines and vaccines (PDF, 1
page, 166 KB) |
| 24/06/2025 |
Consultation outcome |
Outcome of the consultation on the proposal to change the regulatory
and funding restrictions for stimulant treatments for ADHD
|
| 13/06/2025 |
Dear Healthcare Professional Letter |
Risperdal (risperidone): Accidental overdoses in children and
adolescents treated with risperidone 1mg/ml oral solution following
administration errors (PDF, 8 pages, 308 KB) |
| 30/05/2025 |
Alert |
Stop using Euky Bear Warm Steam Vaporiser – model number EBSV2013
|
| 30/05/2025 |
Dear Healthcare Professional Letter |
Ventolin
(salbutamol (as sulfate) aerosol inhaler) - reinforcing information
regarding number of prescribed doses available (PDF, 2 pages,
200 KB) |
| 22/05/2025 |
Dear Healthcare Professional Letter |
Estradiol Transdermal Patches (Mylan) granted full consent;
US packs will continue to be supplied in the short-term
(PDF, 3 pages, 352 KB) |
| 22/05/2025 |
Dear Healthcare Professional Letter |
Zyprexa IM (olanzapine) 10mg powder for injection: Temporary
supply of overseas product (PDF, 2 pages, 226 KB) |
